| Pharmaceutical active ingredients: |
| Sodium Polystyrene Sulfonate |
| Available forms, composition and doses of K-Exit: |
| Powder for Solution; Oral; Rectal; Sodium Polystyrene Sulfonate 100% |
| K-Exit medical category: |
| Human:Potassium-removing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AE01 - Polystyrene Sulfonate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Omega Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Grahamsches Salz | Sodium Polyphosphate | Unidentified Pharmaceutical Company |
| Elutit Natrium | Sodium Polystyrene Sulfonate | Dr. Felgentrager |
| Kalexate | Sodium Polystyrene Sulfonate | KVK-TECH |
| Kayexalate | Sodium Polystyrene Sulfonate | Sanofi-Aventis; C.T.S. Chemical Industries; Institute of Pharmaceutical Research and Technology |
| Kexelate | Sodium Polystyrene Sulfonate | Adcock Ingram |
| K-Exit Poudre | Sodium Polystyrene Sulfonate | Omega Laboratories |
| Kionex | Sodium Polystyrene Sulfonate | Paddock Laboratories |
| Oligo Z | Sodium Polystyrene Sulfonate | Unidentified Pharmaceutical Company |
| PHL-Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Pharmel |
| PMS-Sodium Polysterene Sulfonate | Sodium Polystyrene Sulfonate | Pharmascience |